BPC-157 works primarily through angiogenesis promotion, nitric oxide modulation, and growth factor expression
Yes, Vitamin D injections are available for those with significant deficiencies or absorption issuesadministered by a healthcare provider
This can improve nutrient absorption and overall digestive health, which are crucial for maintaining energy and metabolism [5]
N Engl J Med (2017) 376:64151
GLP-1 receptor agonists (GLP-1 RAs), such as semaglutide, and GLP-1 dual/triple receptor agonists, such as Tirzepatide, have shown significant efficacy in treating type 2 diabetes and obesity
Last month (May 2025), Novo announced that the US Food and Drug Administration (FDA) accepted its new drug application (NDA) submission for an investigational once-daily oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease